Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Post Stem Cell Transplant”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT02561767
What this trial is testing

Effect of BM-MSCs in DCD Kidney Transplantation

Who this might be right for
Kidney TransplantationAcute Kidney Tubular Necrosis
First Affiliated Hospital, Sun Yat-Sen University 120
Testing effectiveness (Phase 2)UnknownNCT02848105
What this trial is testing

Valproic Acid With Methylprenisonlone for the Treatment of Acute GVHD

Who this might be right for
Peripheral Blood Stem Cell TransplantationaGVHD
Shanghai Jiao Tong University School of Medicine 55
Early research (Phase 1)Looking for participantsNCT04013802
What this trial is testing

TETRAVI Multivirus CTL for Treatment of EBV, CMV, Adenovirus, and BK Infections Post Allogeneic SCT.

Who this might be right for
Viral Infection
Baylor College of Medicine 47
Not applicableLooking for participantsNCT03357172
What this trial is testing

Determination of Factors Involved in the Regulation of Immune Responses After Allogeneic Hematopoietic Stem Cell Transplantation

Who this might be right for
Allogeneic Hematopoietic Stem Cell Transplantation
Central Hospital, Nancy, France 700
Not applicableStudy completedNCT05766332
What this trial is testing

Evaluating Clinical Evaluation Tools for Predicting Risk of Complications After Hematopoietic Stem Cell Transplant

Who this might be right for
Hematopoietic and Lymphoid System NeoplasmMalignant Solid Neoplasm
Mayo Clinic 137
Not applicableStudy completedNCT04798495
What this trial is testing

Feasibility of a Rehabilitation Programme Targeted Patients Treated With Non-myeloablative Stem Cell Transplantation

Who this might be right for
Stem Cell TransplantationRehabilitation
Aarhus University Hospital 30
Early research (Phase 1)Not Yet RecruitingNCT07350057
What this trial is testing

A Preliminary Clinical Study on the Efficacy of Cyclophosphamide and Sirolimus Combined With VIC-1911 in Preventing Graft-versus-Host Disease After Haploidentical Stem Cell Transplantation in Children

Who this might be right for
GVHD (Acute or Chronic)
Shanghai Jiao Tong University School of Medicine 9
Testing effectiveness (Phase 2)Study completedNCT00326157
What this trial is testing

PROPHESSOR: AmBisome in Antifungal Primary Prophylaxis Treatment of High Risk Patients Undergoing Allogeneic Stem Cell Transplantation

Who this might be right for
Fungus Diseases
Gilead Sciences 34
Not applicableStudy completedNCT02492100
What this trial is testing

A Multimodal Intervention to Address Sexual Dysfunction in Hematopoietic Stem Cell Transplant Survivors

Who this might be right for
Sexual Dysfunction
Massachusetts General Hospital 47
Not applicableUnknownNCT05200338
What this trial is testing

Preservation and Transfer of HBV Immunity After Allogeneic HSCT for SCD

Who this might be right for
Sickle Cell Disease
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 30
Not applicableLooking for participantsNCT07662018
What this trial is testing

Prospective Observational Study of Outcomes After Gemcitabine, Docetaxel, Melphalan, and Carboplatin With Autologous Stem Cell Transplantation in Pediatric Relapsed/Refractory Germ Cell Tumors

Who this might be right for
Prospective Observational StudyGemcitabineDocetaxel+5 more
M.D. Anderson Cancer Center 30
Testing effectiveness (Phase 2)Study completedNCT01063647
What this trial is testing

Dose-range Finding Treosulfan-based Conditioning

Who this might be right for
Hematological Malignancies
medac GmbH 56
Large-scale testing (Phase 3)UnknownNCT00884338
What this trial is testing

Cognitive Function After Stem Cell Transplantation

Who this might be right for
FatigueCognitive ImpairmentStem Cell Transplantation
Charite University, Berlin, Germany 60
Testing effectiveness (Phase 2)Study completedNCT01525407
What this trial is testing

Donor Atorvastatin Treatment for Preventing Severe Acute Graft-Versus-Host Disease in Patients Undergoing Myeloablative Peripheral Blood Stem Cell Transplantation

Who this might be right for
Malignant Neoplasm
Fred Hutchinson Cancer Center 83
Testing effectiveness (Phase 2)Study completedNCT00778752
What this trial is testing

Dose-finding of Lenalidomide as Maintenance in Multiple Myeloma

Who this might be right for
Multiple Myeloma
Universitätsklinikum Hamburg-Eppendorf 24
Very early researchUnknownNCT02853942
What this trial is testing

Autologous Adipose Mesenchymal Stem Cell Transplantation in the Treatment of Patients With Hemifacial Spasm

Who this might be right for
Injury of Facial Nerve, Unspecified Side, Initial Encounter
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine 100
Testing effectiveness (Phase 2)UnknownNCT05599256
What this trial is testing

Prevention of Severe Acute Graft-versus-host Disease in Pediatric Patients Using a daGOAT Model

Who this might be right for
Transplant-Related Disorder
Institute of Hematology & Blood Diseases Hospital, China 40
Not applicableUnknownNCT03336996
What this trial is testing

Assessement the Reconstruction of Motor Circuits in Nerve Fiber Injuries After the Treatment of Umbilical Cord Mesenchymal Stem Cells With Blood Oxygen Level-dependent Drived Diffusion Tensor Imaging

Who this might be right for
Characterize and Evaluate Functional After TransplantationDetermine the Therapeutic EfficiencyCorrelate the Imaging Results
General Hospital of Ningxia Medical University 40
Not applicableUnknownNCT02888522
What this trial is testing

Pre-emptive Immunomodulation After Allogeneic Stem Cell Transplantation in AML

Who this might be right for
AML
University Hospital, Caen 60
Not applicableLooking for participantsNCT06125483
What this trial is testing

TBI/Flu/Bu/Mel Combined With Secondary UCBT in Patients With Hematological Malignancies Who Relapsed After Allo-HSCT

Who this might be right for
Hematopoietic MalignancyRelapse/RecurrenceHematopoietic Stem Cell Transplantation
The First Affiliated Hospital of Soochow University 38
Next Page